Immatics NV (IMTX)
10.94
+0.13
(+1.20%)
USD |
NASDAQ |
May 17, 16:00
10.94
0.00 (0.00%)
After-Hours: 20:00
Immatics Enterprise Value: 505.00M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 505.00M |
| May 15, 2024 | 532.82M |
| May 14, 2024 | 586.41M |
| May 13, 2024 | 524.58M |
| May 10, 2024 | 507.06M |
| May 09, 2024 | 487.48M |
| May 08, 2024 | 486.45M |
| May 07, 2024 | 495.72M |
| May 06, 2024 | 497.78M |
| May 03, 2024 | 500.88M |
| May 02, 2024 | 513.24M |
| May 01, 2024 | 505.00M |
| April 30, 2024 | 414.31M |
| April 29, 2024 | 419.46M |
| April 26, 2024 | 422.55M |
| April 25, 2024 | 398.85M |
| April 24, 2024 | 436.98M |
| April 23, 2024 | 464.81M |
| April 22, 2024 | 441.10M |
| April 19, 2024 | 443.17M |
| April 18, 2024 | 448.32M |
| April 17, 2024 | 445.23M |
| April 16, 2024 | 460.68M |
| April 15, 2024 | 462.75M |
| April 12, 2024 | 484.39M |
| Date | Value |
|---|---|
| April 11, 2024 | 508.09M |
| April 10, 2024 | 524.58M |
| April 09, 2024 | 528.70M |
| April 08, 2024 | 497.78M |
| April 05, 2024 | 481.30M |
| April 04, 2024 | 494.69M |
| April 03, 2024 | 477.17M |
| April 02, 2024 | 496.75M |
| April 01, 2024 | 529.73M |
| March 31, 2024 | 474.08M |
| March 28, 2024 | 611.59M |
| March 27, 2024 | 672.35M |
| March 26, 2024 | 700.16M |
| March 25, 2024 | 693.98M |
| March 22, 2024 | 688.83M |
| March 21, 2024 | 697.07M |
| March 20, 2024 | 770.19M |
| March 19, 2024 | 730.02M |
| March 18, 2024 | 747.53M |
| March 15, 2024 | 766.07M |
| March 14, 2024 | 765.04M |
| March 13, 2024 | 754.74M |
| March 12, 2024 | 765.04M |
| March 11, 2024 | 790.78M |
| March 08, 2024 | 792.84M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
94.25M
Minimum
Apr 12 2023
861.84M
Maximum
Mar 01 2024
448.40M
Average
456.89M
Median
Apr 13 2021
Enterprise Value Benchmarks
| MorphoSys AG | 2.852B |
| Affimed NV | 15.69M |
| InflaRx NV | -5.240M |
| BioNTech SE | 5.744B |
| CureVac NV | 332.77M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.317M |
| Revenue (Quarterly) | 32.88M |
| Total Expenses (Quarterly) | 47.51M |
| EPS Diluted (Quarterly) | -0.0434 |
| Profit Margin (Quarterly) | -10.09% |
| Earnings Yield | -9.72% |
| Normalized Earnings Yield | -8.389 |